CRYSVITA

Solution for injection, 20mg
RxActive license

Active substance (INN)

burosumab

Pharmaceutical form

Pharmaceutical formSolution for injection
Strength20mg
PackagingUkupno 1 bočica staklena sa 1ml rastvora za injekciju u kartonskoj kutiji
Manufacturerallphamed PHARBIL Arzneimittel GmbH, Germany
Therapeutic groupMusculo-skeletal system (M05BX05)
Marketing authorization holderAMICUS PHARMA DOO PODGORICA
Authorization dateJune 28, 2024

Analogs in Montenegro

2

Other medicines with the same active substance

CRYSVITARx
Solution for injection, 10mgallphamed PHARBIL Arzneimittel GmbH
CRYSVITARx
Solution for injection, 30mgallphamed PHARBIL Arzneimittel GmbH
Source: CInMED register